Promoter Bank clone, Human chemokine receptor (CXCR4) promoter
Alternative name | p1889-18F |
---|---|
Clone info. | PCR amplified human chemokine receptor (CXCR4) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Cloned fragment: 136120778 to 136118108(NC_000002.12); relatively -2623 to +48, where +1 corresponds to 1 nt of NM_003467.2. |
Comment | PCR cloning, forward primer, 1889F-SpeI: 5' gactactagtcaattctgaatcctgccttttgcac 3'; reverse primer, 1889R-SalI: 5' gactgtcgacctcggcgtcactttgctacctg 3'. Entire sequence of promoter region has not been confirmed. Known differences (at least) : T insertion between 136,120,598 and 136,120,599 of NC_000002.12 ; C to T substitution at 136,120,697 of NC_000002.12. |
Vector backbone | pKM2L (RDB04026) (Plasmid) |
Size of vector backbone | 4.2 kb |
Selectable markers | Kan^r |
Gene/insert name | Human chemokine receptor (CXCR4) genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05481 | pKM2L-phCXCR4 | DNA solution |
Materials & Methods section:
The pKM2L-phCXCR4 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05481). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB17940_B0B3p1-1 |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pUC-M13_-100 (Pr0310) Region: MCS, insert 5' Sequence file: RDB17940_B0B3a.seq |
---|
>05481_17940_B0B3_pUC-M13_-100_A04_01_ABI24.ab1 1 NNNNNNNNNN NNNNNGGGNA NNGCNNGGNT TTTCCNNGTC NCGACGTTGT AAAACGACGG 61 CCAGTGCCNA GCTTGCATGC CTGCAGGTCA TTTAAATAGG GATAACAGGG TAATGATTAA 121 GATCTCGAGC TCTAAGCTTC ACATATGCAT GCACTAGTCA ATTCTGAATC CTGCCTTTTG 181 CACTTAATGT TTCATAAGTA TTTCCCCATG TCACTAAAAA TTCTTCACAA ATAACATTCA 241 CGATGTCCAT ATGGAATTTC AGATGTGGAT GAACCAAAAT CTTGTCAACT ATTCCACTAA 301 CAGTGGTTAT TTAGGGATGT TCAGACATTT CACTATTTAA AAAAAAAATG TTTCCACAAA 361 TACCTTTGTG GCATAAGTTT TTATGAGTGG AGTTACTGTT CTGAAGTTCC TGCTGAATAG 421 AAAATGCTTT CCAGTGAGGC TGTCCCAAGC CACATTCCCA TCAGTGACAA GCGAGAGACA 481 GCTGGTCTTT TCAAATCCGG AGACCAAATA TTATCTTTGA AAAAAAATGG ATTTTTGCCT 541 AATTTGGTAG TCACCAAATA GCATCTCATT GTTCTTTTAA TTATCTGCTT CCTTTTAGTA 601 GAGATCCCTA AAAAGATCTG AAAGGAGTCT TCAGATAAAG GAAGGAGCTT TCTTTTGTCT 661 GTCTACAATC AACAAATATT TATTATGCAA ACCATTTTGC TCCGAGTTTT CTCCTCTTTC 721 CCTTTTTGGA CAGATTTGGG AGATCTCACC TTTCAGGTTT TAGACATCGT GCAGGGAGGA 781 GTTTTGAGGT AGGGTGCAGC TTACGGTCCA GGATAAAACA TACTGATTCT GCCACTACCA 841 GGCTTTGTGA AAAGCAAGTC ATGAAAACGC TCTGAAATTC TAGANCTTCA GTAGATAGGA 901 NCTANCGNGT CTATAAAAAT ATGAANATCC TTAAGTTTTA TTAAANATTC NAAAAAAGTA 961 AAAGTGNTTT TACGGNTTTA TTTTCNNTTT NANTTCTTAN NNNNNNNGTT TANTNNAAAG 1021 GANNNNNNNN NGNANACNNN NNANANNNNN NNNNN // |
Primer: hRluc_N_rev (Pr0567) Region: hRluc, intron, insert 3' Sequence file: RDB17940_B0B3b.seq |
>05481_17940_B0B3_hRluc_N_rev_B04_04_ABI24.ab1 1 NNNNNNNNNN NNNNNNNNNN NNNCTNNNNN NNNNNNCNNC CACTGNNGCC CNGTGATCAT 61 GCGTTTGCGT TGCTCGGGGT CGTACACCTT GGAAGCCATG GTGGCTAGCC TATAGTGAGT 121 CGTATTAAGT ACTCTAGCCT TAAGAGCTGT AATTGAACTG GGAGTGGACA CCTGTGGAGA 181 GAAAGGCAAA GTGGATGTCA GTAAGACCAA TAGGTGCCTA TCAGAAACGC AAGAGTCTTC 241 TCTGTCTCGA CAAGCCCAGT TTCTATTGGT CTCCTTAAAC CTGTCTTGTA ACCTTGATAC 301 TTACCTGCCC AGTGCCTCAC GACCAACTTC TGCAGTACCC GGGTGAATTC TACGCGTCGA 361 CCTCGGCGTC ACTTTGCTAC CTGCTGCCGC AGCCAACAAA CTGAAGTTTC TGGCCGCGGC 421 CGGACTTTTA TAAAAACACG CTCCGAGCGC GGCGCATGCG CCGCTGGGGC GGGGAGGGAG 481 AAGGCGGGGT GGGGGAGAGG GGCAGACGCG AGGAAGGAGG GCGCAGGGGC GGGGCGGAGA 541 GGTGCGCGGC TTGGGAAGCC CAGGGGACCC TGCTGTTTGC GGGTGGTCGG TAGTGAGTCC 601 GGAGCCGGAC AGGACCTCCC AGAGGCATTT CCTAAGTTTG AGGGAAGCGG GATGCGCCTG 661 AAGACAGGTG GGAAGCGCGG GCTAGGAACG CGTCTCTCTG TGGCGCGTCC ATCCTTGCTA 721 AAGTGGATGG AATTCCAGAC CTGGGAATGC TACAGTAGAG ACACTGAGGC CCAGGGAANG 781 GGAGTGACTT GCTGGAGTAA CCCAACCNGT ANGCGGCAAT GCTGGAAGTA NGGNCAAGCT 841 TCCNACGCCA TTCCCCGCGC TTTCAGCAGA NGCAGCCCAT TCAGGAGGTA AAAGGAGTNA 901 AGATCCTTCC TTCNGANGAN GTAGCTATAC TTGCNCATTC NCAGCATCNC TNGGGNCNNN 961 NGCNGATAAT TANGAGANAC TTTCAGAANA ANGNNGNANT TGNNNTNNTT CNNGNANNNT 1021 GNTCANNNGN ANNTATGTAN NGNNNNNNNA TTTCATNNNA NCNGNNNNNC NNNNTNCNNN 1081 NNNNNNN // |
Primer: pAxCALNLF1 (Pr0166) Region: hRluc Sequence file: RDB17940_B0B3c.seq |
>05481_17940_B0B3_pAxCALNLF1_C04_07_ABI24.ab1 1 NNNNNNNNNN NNNNNNGNNN NNTCGNNNCG GCCGCTCTAG AATTACTGCT CGTTCTTCAG 61 CACGCGCTCC ACGAAGCTCT TGATGTACTT ACCCATTTCA TCTGGAGCGT CCTCCTGGCT 121 GAAGTGGAGG CCCTTCACCT TCACGAACTC GGTGTTAGGG AACTTCTTAG CTCCCTCGAC 181 AATAGCGTTG GAAAAGAACC CAGGGTCGGA CTCGATGAAC ATCTTAGGCA GATCGTCGCT 241 GGCCCGAAGG TAGGCGTTGT AGTTGCGGAC AATCTGGACG ACGTCGGGCT TGCCTCCCTT 301 AACGAGAGGG ATCTCGCGAG GCCAGGAGAG GGTAGGCCGT CTAACCTCGC CCTTCTCCTT 361 GAATGGCTCC AGGTAGGCAG CGAACTCCTC AGGCTCCAGT TTCCGCATGA TCTTGCTTGG 421 GAGCATGGTC TCGACGAAGA AGTTATTCTC AAGCACCATT TTCTCGCCCT CTTCGCTCTT 481 GATCAGGGCG ATATCCTCCT CGATGTCAGG CCACTCGTCC CAGGACTCGA TCACGTCCAC 541 GACACTCTCA GCATGGACGA TGGCCTTGAT CTTGTCTTGG TGCTCGTAGG AGTAGTGAAA 601 GGCCAGACAA GCCCCCCAGT CGTGGCCCAC AAAGATGATT TTCTTTGGAA GGTTCAGCAG 661 CTCGAACCAA GCGGTGAGGT ACTTGTAGTG ATCCAGGAGG CGATATGAGC CATTCCCGCT 721 CTTGCCGGAC TTACCCATTC CGATCAGATC AGGGATGATG CATCTAGCCA CGGGCTCGAT 781 GTGAGGCACG ACGTGCCTCC ACAGGTAGCT GGAGGCAGCG TTACCATGCA GAAAAATCAC 841 GGCGTTCTCG GCGTGCTTCT CGGAATCATA GTAGTTGATG AAGGANTCCA GCACGTTCNT 901 TTGCTTGCAG CGAGCCCACC ACNGNNGNCC AGNGATCNTG CGTTTGCGTN GCTCGGGGNC 961 NTACNNCTTG GNANGCCNNN NNNNNTANNN NATAGNGANN CGTANNNNNN NNNN // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content